Metaplanet
3350
Nippon Telegraph & Telephone
9432
Toyota Motor
7203
4
Remixpoint
3825
5
Mitsubishi
8058
JP Stock MarketDetailed Quotes
4553 TOWA Pharmaceutical
- 2790
- -50-1.76%
20min DelayMarket Closed Feb 28 15:30 JST
143.73BMarket Cap8.49P/E (Static)
2862High2777Low150.30KVolume2848Open2840Pre Close421.13MTurnover339552wk High0.65%Turnover Ratio51.52MShares248852wk Low391.66EPS TTM64.41BFloat Cap3560Historical High8.49P/E (Static)23.09MShs Float623Historical Low328.59EPS LYR2.99%Amplitude60.00Dividend TTM0.81P/B100Lot Size2.15%Div YieldTTM
TOWA Pharmaceutical News
TOWA Pharmaceutical: Notice of Revision of Dividend Forecasts for the Fiscal Year Ending March 31, 2025 (69th Fiscal Year)
TOWA Pharmaceutical: Supplementary material for the financial results for the third quarter of the year ending March 31, 2025
TOWA Pharmaceutical: Consolidated Financial Results for the Nine Months Ended December 31, 2024 (Based on Japanese GAAP)
TOWA Pharmaceutical: TOWA PHARMACEUTICAL INTEGRATED REPORT 2024
TOWA Pharmaceutical: Towa Pharmaceutical Integrated Report 2024
TOWA Pharmaceutical: Supplementary material for the financial results for the second quarter (interim period) of the year ending March 31, 2025
TOWA Pharmaceutical: Consolidated Financial Results for the Six Months Ended September 30, 2024 (Based on Japanese GAAP)
TOWA Pharmaceutical: Notice of Revisions of Financial Forecasts
TOWA Pharmaceutical: Notice of Settlement of Lawsuit
TOWA Pharmaceutical: Notice of litigation resolution through settlement
TOWA Pharmaceutical: Announcements of individual stocks regarding revised financial forecasts.
TOWA Pharmaceutical: Supplementary materials for the first quarter financial statements of the year ending on March 31st, 2025.
TOWA Pharmaceutical: Consolidated financial results for the three-month period ending June 30, 2024 (based on Japanese accounting standards).
TOWA Pharmaceutical: Announcements of individual stocks: Notification of completion of disposal of treasury stock as stock compensation with transfer restrictions.
TOWA Pharmaceutical: Matters concerning the controlling shareholder.
TOWA Pharmaceutical: Notice of parent company's financial statements etc.
TOWA Pharmaceutical: Notification of disposal of own shares as transfer-restricted stock compensation.
TOWA Pharmaceutical: Announcements of individual stocks related to changes in company executives.
TOWA Pharmaceutical: Announcements of company executives personnel
TOWA Pharmaceutical: Regarding matters related to dominant shareholders.